keyword
https://read.qxmd.com/read/38646498/metastatic-breast-cancer-with-double-heterozygosity-for-the-brca1-and-brca2-genes-responding-to-olaparib-a-case-report
#21
Bin Shao, Lijun Di
Olaparib was the first poly ADP-ribose polymerase inhibitor approved for patients with cancer with mutations in either BRCA1 or BRCA2 in China. To the best of our knowledge, however, no study has described the efficacy of olaparib for patients with breast cancer with double mutations in BRCA1 and BRCA2 . The present case report describes a patient with breast cancer with deleterious germline mutations in both BRCA1 and BRCA2 . The 56-year-old patient with multiple metastatic breast cancer underwent breast cancer resection with 12 years interval between removal of the left and right breast...
June 2024: Oncology Letters
https://read.qxmd.com/read/38646378/care-for-social-isolation-and-loneliness-in-a-case-with-late-onset-delusional-disorder
#22
Hideki Kanemoto, Tatsuhito Kawasaki
Late-onset psychosis refers to the development of psychotic symptoms after the age of 40 and can encompass various conditions like schizophrenia, mood disorders with psychotic features, and delusional disorder. Non-pharmacological interventions are critically important in older adults with psychosis, especially considering the lack of evidence for the efficacy of antipsychotics and the high risk of side effects. Social isolation is recognized as one of the risks of late-onset psychosis, and interventions to eliminate this risk are becoming increasingly important in Japan, where social isolation among older people is widespread as society ages...
March 2024: Curēus
https://read.qxmd.com/read/38645819/traditional-and-innovative-interventions-in-the-management-of-enuresis
#23
REVIEW
Pietro Ferrara, Ignazio Cammisa, Margherita Zona, Antonio Gatto, Roberto Sacco, Alberto Verrotti Di Pianella
INTRODUCTION: Enuresis (NE) is a socially stigmatising and stressful condition affecting children's and parent's quality of life. The aim of this review was to evaluate and summarize the current knowledge about the pharmacological and non-pharmacological traditional and innovative treatments in children with NE. MATERIAL AND METHODS: We examined the following bibliographic electronic databases: PubMed and the Cochrane Library, from January 2000 until July 2023. The search was guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) (8) and was limited to English-language papers that focused on enuresis in patients under 18 years old...
2024: Central European Journal of Urology
https://read.qxmd.com/read/38645732/management-of-contact-lenses-and-visual-development-in-pediatric-aphakia
#24
JOURNAL ARTICLE
Tomris Şengör, Tuğba Gençağa Atakan
Congenital cataract is among the main causes of treatable vision loss in childhood. The first weeks and months of life are a critical time for the development of vision. Therefore, early cataract surgery and effective multifaceted treatment of the resulting aphakia in the early stages of life are of great value for the management of vision development. Among the treatment models, contact lenses (CL) have an important place in infancy and early childhood up to the age of 2 years. Although good visual gains were not considered very likely, especially in unilateral aphakia, important steps have been taken in the treatment of pediatric aphakia thanks to the surgical techniques developed over time and the increasing experience with optical correction systems, especially CLs...
April 19, 2024: Turkish Journal of Ophthalmology
https://read.qxmd.com/read/38645685/impact-of-systemic-therapy-on-fertility-in-women-with-early-stage-breast-cancer
#25
JOURNAL ARTICLE
Kelsey H Natsuhara, A Jo Chien
PURPOSE OF REVIEW: Fertility concerns are common among young women diagnosed with breast cancer, as systemic therapy increases the risk of premature ovarian insufficiency and delays family planning. Here, we review the impact of systemic therapies, including chemotherapy, endocrine therapy, HER-2 directed therapy, PARP inhibitors, and immunotherapy, on ovarian reserve. RECENT FINDINGS: With an improved understanding of disease biology, fewer women are treated with gonadotoxic chemotherapy...
March 2024: Current Breast Cancer Reports
https://read.qxmd.com/read/38645554/surufatinib-combined-with-photodynamic-therapy-induces-ferroptosis-to-inhibit-cholangiocarcinoma-in-vitro-and-in-tumor-models
#26
JOURNAL ARTICLE
Yun-Peng Huang, Yong-Xiang Wang, Hui Zhou, Zhong-Tao Liu, Zi-Jian Zhang, Li Xiong, Heng Zou, Yu Wen
The curative effect of single therapy for advanced cholangiocarcinoma (CCA) is poor, thus investigating combined treatment strategies holds promise for improving prognosis. Surufatinib (SUR) is a novel multikinase inhibitor that has been confirmed to prolong survival of patients with advanced CCA. Photodynamic therapy (PDT) can also ablate advanced CCA and relieve biliary obstruction. In this study, we explored the anti-CCA effect of SUR combined with PDT, and explored the underlying mechanism. We found that SUR could effectively inhibit the abilities of proliferation, migration and metastasis in CCA cells (HUCCT-1, RBE)...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38645235/harnessing-molecular-mechanism-for-precision-medicine-in-dilated-cardiomyopathy-caused-by-a-mutation-in-troponin-t
#27
Lina Greenberg, W Tom Stump, Zongtao Lin, Andrea L Bredemeyer, Thomas Blackwell, Xian Han, Akiva E Greenberg, Benjamin A Garcia, Kory J Lavine, Michael J Greenberg
UNLABELLED: Familial dilated cardiomyopathy (DCM) is frequently caused by autosomal dominant point mutations in genes involved in diverse cellular processes, including sarcomeric contraction. While patient studies have defined the genetic landscape of DCM, genetics are not currently used in patient care, and patients receive similar treatments regardless of the underlying mutation. It has been suggested that a precision medicine approach based on the molecular mechanism of the underlying mutation could improve outcomes; however, realizing this approach has been challenging due to difficulties linking genotype and phenotype and then leveraging this information to identify therapeutic approaches...
April 9, 2024: bioRxiv
https://read.qxmd.com/read/38645083/folate-receptor-alpha-protein-expression-in-ovarian-serous-cystadenocarcinoma-tumors-of-the-cancer-genome-atlas-exploration-beyond-single-agent-therapy
#28
Christianne Persenaire, Benjamin G Bitler, Bradley R Corr
UNLABELLED: Epithelial ovarian cancer (EOC) can be highly lethal, with limited therapeutic options for patients with non-homologous recombination deficient (HRD) disease. Folate receptor alpha (FOLR1/FRα)-targeting agents have shown promise both alone and in combination with available therapies, but the relationship of FRα to other treatment-driving biomarkers is unknown. The Cancer Genome Atlas (TCGA) was queried to assess protein and mRNA expression and mutational burden in patients with differential FRα protein-expressing ovarian tumors, and the results referenced against the standard 324 mutations currently tested through FoundationOne Companion Diagnostics to identify targets of interest...
April 14, 2024: medRxiv
https://read.qxmd.com/read/38645018/a-heterogeneous-pharmaco-transcriptomic-landscape-induced-by-targeting-a-single-oncogenic-kinase
#29
Ross M Giglio, Nicholas Hou, Adeya Wyatt, Justin Hong, Lingting Shi, Mathini Vaikunthan, Henry Fuchs, Jose Pomarino Nima, Seth W Malinowski, Keith L Ligon, José R McFaline-Figueroa, Nir Yosef, Elham Azizi, José L McFaline-Figueroa
UNLABELLED: Over-activation of the epidermal growth factor receptor (EGFR) is a hallmark of glioblastoma. However, EGFR-targeted therapies have led to minimal clinical response. While delivery of EGFR inhibitors (EGFRis) to the brain constitutes a major challenge, how additional drug-specific features alter efficacy remains poorly understood. We apply highly multiplex single-cell chemical genomics to define the molecular response of glioblastoma to EGFRis. Using a deep generative framework, we identify shared and drug-specific transcriptional programs that group EGFRis into distinct molecular classes...
April 10, 2024: bioRxiv
https://read.qxmd.com/read/38644708/navigating-the-alzheimer-s-treatment-landscape-unraveling-amyloid-beta-complexities-and-pioneering-precision-medicine-approaches
#30
JOURNAL ARTICLE
Mohsina Patwekar, Faheem Patwekar, Shahzad Khan, Rohit Sharma, Dileep Kumar
A variety of cutting-edge methods and good knowledge of the illness's complex causes are causing a sea change in the field of Alzheimer's Disease (A.D.) research and treatment. Precision medicine is at the vanguard of this change, where individualized treatment plans based on genetic and biomarker profiles give a ray of hope for customized therapeutics. Combination therapies are becoming increasingly popular as a way to address the multifaceted pathology of Alzheimer's by simultaneously attacking Aβ plaques, tau tangles, neuroinflammation, and other factors...
April 19, 2024: Current Topics in Medicinal Chemistry
https://read.qxmd.com/read/38644601/quality-of-life-in-children-and-adolescents-after-treatment-for-acute-lymphoblastic-leukemia-according-to-the-nopho-all2008-protocol
#31
JOURNAL ARTICLE
Nina Mogensen, Ulrika Kreicbergs, Birgitte Klug Albertsen, Päivi M Lähteenmäki, Mats Heyman, Arja Harila
BACKGROUND: The improved outcome of childhood acute lymphoblastic leukemia (ALL) over the last decades has increased the importance of assessing late effects and health-related quality of life (HRQoL), particularly when evaluating and comparing outcomes in clinical trials. This study aimed to assess HRQoL in children treated for ALL according to the NOPHO ALL2008 protocol. PROCEDURE: Children, aged 1 to less than 18 years at diagnosis, alive in first remission, and their parents, were asked to complete PedsQL 4...
April 21, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38643673/enhanced-identification-of-familial-hypercholesterolemia-using-central-laboratory-algorithms
#32
JOURNAL ARTICLE
Shirin Ibrahim, Nick S Nurmohamed, Melchior C Nierman, Jim N de Goeij, Linda Zuurbier, Jeroen van Rooij, Willemijn A M Schonck, Jard de Vries, G Kees Hovingh, Laurens F Reeskamp, Erik S G Stroes
BACKGROUND AND AIMS: Familial hypercholesterolemia (FH) is a highly prevalent genetic disorder resulting in markedly elevated LDL cholesterol levels and premature coronary artery disease. FH underdiagnosis and undertreatment require novel detection methods. This study evaluated the effectiveness of using an LDL cholesterol cut-off ≥99.5th percentile (sex- and age-adjusted) to identify clinical and genetic FH, and investigated underutilization of genetic testing and undertreatment in FH patients...
April 13, 2024: Atherosclerosis
https://read.qxmd.com/read/38643567/a-path-from-synthesis-to-emergency-use-authorization-of-molnupiravir-as-a-covid-19-therapy
#33
REVIEW
Norein Sakander, Ajaz Ahmed, Mahir Bhardwaj, Diksha Kumari, Utpal Nandi, Debaraj Mukherjee
Coronaviruses are a group of enveloped viruses with non-segmented, single-stranded, and positive-sense RNA genomes. It belongs to the 'Coronaviridae family', responsible for various diseases, including the common cold, SARS, and MERS. The COVID-19 pandemic, which began in March 2020, has affected 209 countries, infected over a million people, and claimed over 50,000 lives. Significant efforts have been made by repurposing several approved drugs including antiviral, to combat the COVID-19 pandemic. Molnupiravir is found to be the first orally acting efficacious drug to treat COVID-19 cases...
April 17, 2024: Bioorganic Chemistry
https://read.qxmd.com/read/38643314/addressing-comprehensive-complexities-a-striking-familial-hypercholesterolemia-case-study
#34
JOURNAL ARTICLE
Shazia Rasheed, Ghulam Kubra, Lubna Baqai, Muhammad Liaquat Raza, Fariha Hassan, Syed Ghazi Abbas Rizvi
BACKGROUND: Premature aortic involvement and comprehensive management strategies in familial hypercholesterolemia familial hypercholesterolemia (FH), a rare autosomal dominant genetic disorder, poses significant challenges due to its propensity for elevated low-density lipoprotein cholesterol, premature coronary heart disease, and vascular atherosclerosis. CASE PRESENTATION: Unraveling Cardiovascular Complexities: A Striking Familial Hypercholesterolemia. This case study delves into a remarkable instance of FH in a 16-year-old female who presented with chest pain and worsening dyspnea...
April 20, 2024: Egyptian Heart Journal: EHJ
https://read.qxmd.com/read/38643203/a-novel-engineered-il-21-receptor-arms-t-cell-receptor-engineered-t-cells-tcr-t-cells-against-hepatocellular-carcinoma
#35
JOURNAL ARTICLE
Wei Zhu, Zhiming Zhang, Jinzhang Chen, Xiaolan Chen, Lei Huang, Xiaoyong Zhang, Xuan Huang, Na Ma, Weikang Xu, Xuan Yi, Xinyu Lu, Xin Fu, Siwei Li, Guoheng Mo, Yiyue Wang, Guosheng Yuan, Mengya Zang, Qi Li, Xiaotao Jiang, Yajing He, Sha Wu, Yukai He, Yongyin Li, Jinlin Hou
Strategies to improve T cell therapy efficacy in solid tumors such as hepatocellular carcinoma (HCC) are urgently needed. The common cytokine receptor γ chain (γc ) family cytokines such as IL-2, IL-7, IL-15 and IL-21 play fundamental roles in T cell development, differentiation and effector phases. This study aims to determine the combination effects of IL-21 in T cell therapy against HCC and investigate optimized strategies to utilize the effect of IL-21 signal in T cell therapy. The antitumor function of AFP-specific T cell receptor-engineered T cells (TCR-T) was augmented by exogenous IL-21 in vitro and in vivo...
April 20, 2024: Signal Transduction and Targeted Therapy
https://read.qxmd.com/read/38643025/migraine-treatment-consensus-document-of-the-spanish-society-of-neurology-sen-spanish-society-of-family-and-community-medicine-semfyc-society-of-primary-care-medicine-semergen-and-spanish-association-of-migraine-and-headache-aemice-on-migraine-treatment
#36
Robert Belvís, Pablo Irimia, Nuria González, Jésica García-Ull, Patricia Pozo-Rosich, Alba López-Bravo, Noemí Morollón, Sonia Quintas, Antoni Plana, Pablo Gregorio Baz, Ana Tentor, Natalia Gallego Artiles, Francisco Javier León, Miguel Pérez Martín, Inés Rivera, Raquel Ramírez, Isabel Colomina, José Miguel Lainez, Julio Pascual
Migraine is a disease with a high prevalence and incidence, in addition to being highly disabling, causing a great impact on the patient's quality of life at a personal, family and work level, but also social, given its high expense due to its direct (care) and indirect (presenteeism and work absenteeism) costs. The multiple and recent developments in its pathophysiological knowledge and in its therapy require updating and, therefore, in this article the Spanish scientific societies most involved in its study and treatment (SEN, SEMFYC and SEMERGEN), together with the Association Spanish Association for Patients with Migraine and other Headaches (AEMICE), we have developed these updated care recommendations...
April 19, 2024: Medicina Clínica
https://read.qxmd.com/read/38642796/egfr-inhibition-by-erlotinib-rescues-desmosome-ultrastructure-and-keratin-anchorage-and-protects-against-pemphigus-vulgaris-igg-induced-acantholysis-in-human-epidermis
#37
JOURNAL ARTICLE
Desalegn Tadesse Egu, Thomas Schmitt, Nancy Ernst, Ralf Joachim Ludwig, Michael Fuchs, Matthias Hiermaier, Sina Moztarzadeh, Carla Sebastià Morỏn, Enno Schmidt, Vivien Beyersdorfer, Volker Spindler, Letyfee Sarah Steinert, Franziska Vielmuth, Anna Magdalena Sigmund, Jens Waschke
Pemphigus is a severe blistering disease caused by autoantibodies primarily against the desmosomal cadherins desmoglein (DSG)1 and DSG3 which impair desmosome integrity. Especially for the acute phase, additional treatment options allowing to reduce corticosteroids would fulfill an unmet medical need. Here, we provide evidence that epidermal growth factor receptor (EGFR) inhibition by erlotinib ameliorates pemphigus vulgaris immunoglobulin G (PV-IgG) -induced acantholysis in intact human epidermis. PV-IgG caused phosphorylation of EGFR (Y845) and SRC in human epidermis...
April 18, 2024: Journal of Investigative Dermatology
https://read.qxmd.com/read/38642577/challenging-diagnosis-of-resistance-to-thyroid-hormone-in-a-patient-with-covid-19-pituitary-microadenoma-and-unusual-response-to-octreotide-long-acting-release-test
#38
JOURNAL ARTICLE
Cristian Petolicchio, Sara Brasili, Stefano Gay, Francesco Cocchiara, Irene Campi, Luca Persani, Lara Vera, Diego Ferone, Federico Gatto
SUMMARY: The resistance to thyroid hormone syndrome (RTHβ) occurs uncommonly and requires a high level of clinical suspicion and specific investigations to reach a precise diagnosis and to avoid unnecessary and potentially harmful therapies. We report a case of a young male patient referred to our unit for SARS-CoV-2 infection and atrial fibrillation with elevated thyroid hormones and non-suppressed thyroid-stimulating hormone (TSH), for which antithyroid therapy was prescribed...
April 1, 2024: Endocrinology, Diabetes & Metabolism Case Reports
https://read.qxmd.com/read/38642396/adapting-a-financial-incentives-intervention-for-smoking-cessation-with-alaska-native-families-phase-1-qualitative-research-to-inform-the-aniqsaaq-to-breathe-study
#39
JOURNAL ARTICLE
Pamela S Sinicrope, Brianna N Tranby, Antonia M Young, Kathryn R Koller, Diane K King, Flora R Lee, Corinna V Sabaque, Judith J Prochaska, Bijan J Borah, Paul A Decker, Michael G McDonell, Barbara Stillwater, Timothy K Thomas, Christi A Patten
INTRODUCTION: Alaska Native and American Indian (ANAI) peoples in Alaska currently experience a disproportionate burden of morbidity and mortality from tobacco cigarette use. Financial incentives for smoking cessation are evidence-based, but a family-level incentive structure has not been evaluated. We used a community-based participatory research and qualitative approach to culturally adapt a smoking cessation intervention with ANAI families. METHODS: We conducted individual, semi-structured telephone interviews with 12 ANAI adults who smoke, 12 adult family members, and 13 Alaska Tribal Health System stakeholders statewide between November 2022-March 2023...
April 20, 2024: Nicotine & Tobacco Research
https://read.qxmd.com/read/38641832/nr1h4-disease-rapidly-progressing-neonatal-intrahepatic-cholestasis-and-early-death
#40
JOURNAL ARTICLE
Zhong-Die Li, Yu-Chuan Li, Jing-Zhao, Jian-She Wang, Xin-Bao Xie
BACKGROUND: Clinical studies on progressive familial intrahepatic cholestasis (PFIC) type 5 caused by mutations in NR1H4 are limited. METHODS: New patients with biallelic NR1H4 variants from our center and all patients from literature were retrospectively analyzed. RESULTS: Three new patients were identified to be carrying five new variants. Liver phenotypes of our patients manifests as low-γ-glutamyl transferase cholestasis, liver failure and related complications...
April 19, 2024: Orphanet Journal of Rare Diseases
keyword
keyword
9238
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.